(Q48558097)

12 February 2018

title

Neuroprotection afforded by a combination of eliprodil and a thrombolytic agent, rt-PA, in a rat thromboembolic stroke model. (English)

1 reference

12 February 2018

1 reference

1 reference

Lekieffre D

1

1 reference

12 February 2018

Benavides J

series ordinal

2

1 reference

12 February 2018

Scatton B

series ordinal

3

1 reference

12 February 2018

Nowicki JP

series ordinal

4

1 reference

12 February 2018

language of work or name

English

0 references

publication date

1 November 1997

1 reference

12 February 2018

published in

Brain Research

1 reference

12 February 2018

volume

776

1 reference

12 February 2018

issue

1-2

1 reference

12 February 2018

page(s)

88-95

1 reference

12 February 2018

Monoclonal antibody to the ICAM-1 adhesion site reduces neurological damage in a rabbit cerebral embolism stroke model

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900992-X

Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischemic damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900992-X

The quantification of cerebral infarction following focal ischemia in the rat: influence of strain, arterial pressure, blood glucose concentration, and age.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900992-X

Clinical and instrumental evaluation of patients with ischemic stroke within the first six hours.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900992-X

Evolving toward effective therapy for acute ischemic stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900992-X

31P spectroscopy in thrombolytic treatment of experimental cerebral infarct

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900992-X

Tissue plasminogen activator for acute ischemic stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900992-X

Reduction of infarct volume and mortality by thrombolysis in a rat embolic stroke model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900992-X

Neuroprotection with NBQX and thrombolysis with rt-PA in rat embolic stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900992-X

Effect of delayed thrombolysis with rt-PA in a rat embolic stroke model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900992-X

Recombinant human tissue-type plasminogen activator therapy in acute thromboembolic stroke.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900992-X

Excitatory amino acid receptor antagonists: a novel treatment for ischemic cerebrovascular diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900992-X

Neuroprotection by excitatory amino acid antagonist augments the benefit of thrombolysis in embolic stroke in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900992-X

Prevention by eliprodil (SL 82.0715) of traumatic brain damage in the rat. Existence of a large (18 h) therapeutic window.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900992-X

Tissue plasminogen activator reduces neurological damage after cerebral embolism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900992-X

Tissue Plasminogen Activator Plus Glutamate Antagonist Improves Outcome After Embolic Stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900992-X

10.1016/S0006-8993(97)00992-X

7 January 2021

Identifiers

DOI

1 reference

12 February 2018

1 reference

12 February 2018